Many viruses inhibit the expression of host genes. In most cases the role of the virus-induced inhibition of host gene expression is to inhibit the host antiviral response, particularly the synthesis of type I (alpha/beta) interferons. An important consequence of the inhibition of host gene expression is that it may promote programmed cell death or apoptosis in host cells. The proposed experiments address the mechanisms of inhibition of host gene expression and the consequences of this inhibition for viral induction of an interferon response or induction of apoptosis using the prototype rhabdovirus, vesicular stomatitis virus (VSV). We have established that the viral matrix (M) protein plays a major role in the inhibition of host gene expression by VSV.
Aim 1 is to determine the mechanism of inhibition of host transcription by M protein. We have shown that inhibition of host RNA polymerase II-dependent transcription is due to inactivation of the basal transcription factor TFIID. We will determine changes that have occurred in TFIID from infected cells that account for the inhibition using immuno-affinity purified, epitope-tagged TFIID.
Aim 2 is to determine the mechanism by which M protein regulates type I interferon gene expression in host cells. We will determine the extent to which M protein inhibits interferon gene expression by inhibition of basal transcription factors, upstream activators of interferon gene expression, or nuclear-cytoplasmic transport of interferon mRNA.
Aim 3 is to determine the mechanism by which M protein regulates induction of apoptosis in host cells. We have established that M protein is a potent inducer of apoptosis when expressed in the absence of other viral components. However, there are at least two VSV components that contribute to induction of apoptosis in the context of a virus infection. We will analyze the molecular components involved in activation of apoptosis by M protein and the other viral component. Infectious VSV cDNA clones will be used to identify other viral components involved in the induction of apoptosis by mapping the sequences of previously isolated viral mutants that enhance their ability to induce apoptosis. These experiments will provide a clearer understanding of the molecular basis for viral pathogenesis including the mechanism for the inhibition of host transcription, the inhibition of interferon production, and the activation of apoptosis. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI032983-08
Application #
6706237
Study Section
Virology Study Section (VR)
Program Officer
Challberg, Mark D
Project Start
1994-05-01
Project End
2008-01-31
Budget Start
2004-02-01
Budget End
2005-01-31
Support Year
8
Fiscal Year
2004
Total Cost
$287,417
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Biochemistry
Type
Schools of Medicine
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Westcott, Marlena M; Liu, Jingfang; Rajani, Karishma et al. (2015) Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis. J Virol 89:7944-54
Yu, Nanmeng; Puckett, Shelby; Antinozzi, Peter A et al. (2015) Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer. J Virol 89:5250-63
Smedberg, Jason R; Westcott, Marlena M; Ahmed, Maryam et al. (2014) Signaling pathways in murine dendritic cells that regulate the response to vesicular stomatitis virus vectors that express flagellin. J Virol 88:777-85
Blackham, Aaron U; Northrup, Scott A; Willingham, Mark et al. (2014) Molecular determinants of susceptibility to oncolytic vesicular stomatitis virus in pancreatic adenocarcinoma. J Surg Res 187:412-26
Blackham, Aaron U; Northrup, Scott A; Willingham, Mark et al. (2013) Variation in susceptibility of human malignant melanomas to oncolytic vesicular stomatitis virus. Surgery 153:333-43
Westcott, Marlena M; Ahmed, Maryam; Smedberg, Jason R et al. (2013) Preservation of dendritic cell function during vesicular stomatitis virus infection reflects both intrinsic and acquired mechanisms of resistance to suppression of host gene expression by viral M protein. J Virol 87:11730-40
Stewart 4th, J H; Ahmed, M; Northrup, S A et al. (2011) Vesicular stomatitis virus as a treatment for colorectal cancer. Cancer Gene Ther 18:837-49
Gerlier, Denis; Lyles, Douglas S (2011) Interplay between innate immunity and negative-strand RNA viruses: towards a rational model. Microbiol Mol Biol Rev 75:468-90, second page of table of
Cary, Zachary D; Willingham, Mark C; Lyles, Douglas S (2011) Oncolytic vesicular stomatitis virus induces apoptosis in U87 glioblastoma cells by a type II death receptor mechanism and induces cell death and tumor clearance in vivo. J Virol 85:5708-17
Ahmed, M; Puckett, S; Lyles, D S (2010) Susceptibility of breast cancer cells to an oncolytic matrix (M) protein mutant of vesicular stomatitis virus. Cancer Gene Ther 17:883-92

Showing the most recent 10 out of 32 publications